Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04759586
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2021-02-17
Brief Title:
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-17
First Submit QC Date:
February 17 2021
Study First Post Date:
2021-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-22
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED